NIMBLEHEART, INC – FDA 483, Jun 27, 2025
NIMBLEHEART, INC in Sunnyvale, CA, a manufacturer of the Class 2 Physiotrace Smart System, was inspected by the FDA and received nine observations. The inspection revealed significant deficiencies across multiple quality system areas, including inadequate procedures for design changes, corrective and preventive actions, complaint handling, management reviews, internal audits, product identification, non-conforming product control, supplier management, and equipment maintenance. These issues indicate a systemic failure to establish and maintain an effective quality system.
ID · ddad5596-d82a-4a12-8db4-436ee56c5ba4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.